Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 211.40
+0.54 (0.26%)
Oct 23, 2026, 3:30 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 13.94 billion as of October 22, 2026. It is the 22,586th most valuable company in the world and the 1,416th biggest in India. Its market cap has decreased by 5.71% in one year.
Market Cap
13.94B
Enterprise Value
12.96B
Revenue
2.94B
Global Rank
Country Rank
#1,416 India
PE Ratio
31.54
ChartMarket Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 13.94B, a decrease of -20.95%. That is a compound annual growth rate of -0.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 13.94B | 8.36% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Solara Active Pharma Sciences | 30.04B |
| Ind-Swift Laboratories | 30.00B |
| Sakar Healthcare | 21.23B |
| Indoco Remedies | 20.79B |
| Beta Drugs | 19.98B |
| Windlas Biotech | 18.66B |
| Anlon Healthcare | 12.94B |
| Bafna Pharmaceuticals | 10.69B |